Stay updated with breaking news from Segments Profiled. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prophylactic HIV Drugs IndustryThe prophylactic HIV drugs industry size is projected to be worth US$32,516.1 million in 2023 and US$31,278.5 million in 2022.Growth in the market is primarily due to increased R&D investment in HIV clinical trials by pharmaceutical and biotechnology companies, increased HIV drug appr...
It is projected that the global liquid biopsy industry would generate US$ 1,538.3 million in revenue by 2023. According to our healthcare domain specialists, liquid biopsy providers should anticipate strong growth, with a projected revenue of US$ 10,938.6 million by 2033 and a CAGR of 21.7% through that year.One of...
Urinary Retention Therapeutics IndustryThe global urinary retention therapeutics industry size is anticipated to attain an impressive valuation of US$ 3.44 billion in 2023 and is projected to reach US$ 7.5 billion by 2033, expected to register a CAGR of 8.11% until 2033, as per a recently published Future Market Ins...
Unstable Angina Therapeutics MarketAccording to a recently published Future Market Insights report, the global unstable angina therapeutics market is forecast to expand at a CAGR of 5% until 2033, reaching US$ 6.6 billion. Based on a Cleveland Clinic study, approximately 200,000 Americans suffer from unstable angina...
The Chronic Refractory Cough Treatment Market refers to the pharmaceutical and healthcare sector that focuses on providing treatments for chronic refractory cough (CRC). Chronic refractory cough is a persistent cough that does not respond to standard cough treatments and lasts for more than eight weeks. It can signi...